Information  X 
Enter a valid email address

Company Name matching 'Erytech Pharma S.A.'

Date
Time Source
Company
Announcement
07 Jul 2022 5:00 pm GNW   Erytech Pharma S.A. Monthly information related to total number of voting rights and shares composing the share capital _June 30, 2022.
24 Jun 2022 9:05 pm GNW   Erytech Pharma S.A. Report – ERYTECH’s Combined Shareholders’ Meeting On June 24, 2022
03 Jun 2022 5:00 pm GNW   Erytech Pharma S.A. Monthly information related to total number of voting rights and shares composing the share capital _May 31, 2022.
24 May 2022 9:05 pm GNW   Erytech Pharma S.A. ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 24, 2022
17 May 2022 9:05 pm GNW   Erytech Pharma S.A. ERYTECH to Present at the H.C. Wainwright Global Investment Conference
13 May 2022 5:00 pm GNW   Erytech Pharma S.A. Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2022
12 May 2022 9:05 pm GNW   Erytech Pharma S.A. ERYTECH Provides Business and Financial Update for the First Quarter of 2022
28 Apr 2022 9:05 pm GNW   Erytech Pharma S.A. ERYTECH Announces Filing of 2021 Universal Registration Document and 2021 Annual Report on Form 20-F, as well as its 2022 financial calendar
25 Apr 2022 7:00 am GNW   Erytech Pharma S.A. ERYTECH Sells U.S. Manufacturing Facility and Enters Long-Term Supply Agreement with Catalent
06 Apr 2022 9:05 pm GNW   Erytech Pharma S.A. ERYTECH Announces Publication of Positive Results from Eryaspase Phase 2 Trial in Hypersensitive ALL in the British Journal of Haematology
  6:00 pm GNW   Erytech Pharma S.A. Monthly information related to total number of voting rights and shares composing the share capital – March 31, 2022
04 Apr 2022 6:30 am GNW   Erytech Pharma S.A. ERYTECH to Present Novel Vesiculation Approach at the 24th Meeting of the European Red Cell Society
28 Mar 2022 9:05 pm GNW   Erytech Pharma S.A. ERYTECH to Participate in the Upcoming April Investor Conferences
11 Mar 2022 10:18 pm GNW   Erytech Pharma S.A. ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2021
04 Mar 2022 5:00 pm GNW   Erytech Pharma S.A. Monthly information related to total number of voting rights and shares composing the share capital – February 28, 2022
08 Feb 2022 9:05 pm GNW   Erytech Pharma S.A. ERYTECH Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases
  5:00 pm GNW   Erytech Pharma S.A. Monthly information related to total number of voting rights and shares composing the share capital – January 31, 2022
24 Jan 2022 6:30 am GNW   Erytech Pharma S.A. ERYTECH Announces Presentation of Results of Two Clinical Trials of Eryaspase in Pancreatic Cancer at ASCO GI
10 Jan 2022 5:00 pm GNW   Erytech Pharma S.A. Monthly information related to total number of voting rights and shares composing the share capital – December 31, 2021
14 Dec 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic Cancer
10 Dec 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Present at the JMP Securities Hematology Summit
07 Dec 2020 7:00 am GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces Positive Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia Presented at the American Society of Hematology Annual Meeting
03 Dec 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces Conference Webcast to Discuss Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia to be Presented at the American Society of Hematology 2020 Annual Meeting
12 Nov 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Present at Jefferies Virtual Healthcare Conference
05 Nov 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Provides Business Update and Reports Financial Results for the Third Quarter of 2020
  7:00 am GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces Abstract with Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia Selected for Oral Presentation at the American Society of Hematology 2020 Annual Meeting
04 Nov 2020 5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2020.
02 Nov 2020 8:19 am GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Secures €10 Million in Non-Dilutive Financing, Guaranteed by the French Government
29 Oct 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Host Third Quarter 2020 Conference Call and Business Update on November 6, 2020
26 Oct 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Appoints Stewart Craig as Chief Technical Officer
12 Oct 2020 10:51 am GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital - September 30, 2020
21 Sep 2020 9:45 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2020
  9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH establishes a financing facility with the implementation of an at-the-market program on Nasdaq with Cowen
16 Sep 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Host on September 22, 2020 Second Quarter 2020 Conference Call and Business Update
14 Sep 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces the Hosting of a KOL Event as the TRYbeCA-1 Phase 3 Trial in Second-line Pancreatic Cancer Nears Complete Enrollment
  5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – August 31, 2020
06 Aug 2020 5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – July 31, 2020
10 Jul 2020 5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – June 30, 2020
26 Jun 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Reports Voting Results from its Annual General Meeting Held on June 26, 2020
25 Jun 2020 7:00 am GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH extends its cash horizon by implementing a convertible bond financing
09 Jun 2020 5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – May 30, 2020
  6:30 am GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Provides Update on Phase 2 Investigator Sponsored Trial of Eryaspase in Second-Line Acute Lymphoblastic Leukemia
02 Jun 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Participate Fireside Chat at Jefferies Virtual Healthcare Conference
01 Jun 2020 6:30 am GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces Poster Presentations at ASCO 2020 Annual Meeting
07 May 2020 5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2020
06 May 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Provides Business Update and Reports Cash Balance at End of Q1 2020
05 May 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH engages in collaborative partnership with EU Horizon 2020 EVIDENCE consortium
30 Apr 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Host on May 7, 2020 First Quarter Conference Call and Business Update
28 Apr 2020 11:13 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Granted U.S. FDA Fast Track Designation for eryaspase in Second-Line Pancreatic Cancer
  9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Provides Update on the TRYbeCA-1 Phase 3 Clinical Trial of Eryaspase in Second Line Pancreatic Cancer
20 Apr 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Provides Update on the TRYbeCA-1 Phase 3 Clinical Trial of Eryaspase in Second Line Pancreatic Cancer
06 Apr 2020 5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – March 31, 2020
19 Mar 2020 10:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces Filing of 2019 Universal Registration Document and 2019 Annual Report on Form 20-F
16 Mar 2020 10:05 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2019
  6:30 am GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Announces the Appointment of Dr. Melanie Rolli to its Board of Directors
12 Mar 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Host Fourth Quarter and Full Year 2019 Conference Call and Business Update
06 Mar 2020 5:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) Monthly information related to total number of voting rights and shares composing the share capital – February 29, 2020
26 Feb 2020 10:00 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH to Present at Cowen and Company 40th Annual Health Care Conference
20 Feb 2020 9:30 pm GNW Factsheet Erytech Pharma S.A. (0QSS) ERYTECH Enters Into Strategic Supply Partnership with the German Red Cross Blood Donor Service


Company Announcements Archive »


a d v e r t i s e m e n t